Schaeffer's Top Stock Picks for '25

Moderna Stock Falls Despite Efficacy Update

Year-to-date, MRNA sports a 27.5% deficit

Deputy Editor
Mar 23, 2022 at 10:35 AM
facebook X logo linkedin


Moderna Inc (NASDAQ:MRNA) stock is down 4.2% at at $178.82 this morning, after the company released efficacy data for its two-dose Covid-19 vaccine for children under 6 years of age. According to Moderna, the vaccine has around a 44% efficacy rate at preventing infection from omicron in Children 6 months to under 2 years old, and is about 38% effective for children aged 2 to 5. The company will ask the Food and Drug Administration (FDA) to grant emergency use authorization (EUA) for the vaccine in children under 6 as soon as possible.

On the charts, Moderna stock scraped the $120 level earlier in the month, an area that hadn't been encountered for nearly 12 months. Now, the shares are up 16.7% for the month and have toppled several shorter-term moving averages along the way.

The options pits have been pessimistic, with puts popular over the last 10 weeks. Over at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), MRNA sports a 50-day put/call volume ratio of 1.12 that sits higher than 94% of annual readings. This suggests long puts are getting picked up at a much quicker-than-usual pace.  

It's also worth noting the equity's Schaeffer's Volatility Scorecard (SVS) sits at 97 out of 100, suggesting the stock has exceeded options traders' volatility expectations in the past year.

 

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?